Company Registration No. 11592190 (England and Wales)
E.P.G Pharma Ltd
Unaudited accounts
for the year ended 30 September 2024
E.P.G Pharma Ltd
Unaudited accounts
Contents
E.P.G Pharma Ltd
Company Information
for the year ended 30 September 2024
Director
Sherif Mohamed Aboelnaga Elmasry
Company Number
11592190 (England and Wales)
Registered Office
MEDICITY NOTTINGHAM D6 BUILDING
THANE ROAD
NOTTINGHAM
NG90 6BH
ENGLAND
Accountants
KM Accountancy Services Ltd
1000
Great West Rd
United Business Centre
Brentford, London
TW8 9DW
E.P.G Pharma Ltd
Statement of financial position
as at 30 September 2024
Cash at bank and in hand
1,974
5,272
Creditors: amounts falling due within one year
(156,393)
(118,367)
Net current liabilities
(114,422)
(84,398)
Total assets less current liabilities
(113,863)
(82,689)
Creditors: amounts falling due after more than one year
(11,665)
(14,190)
Net liabilities
(125,528)
(96,879)
Profit and loss account
(125,528)
(96,879)
Shareholders' funds
(125,528)
(96,879)
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 13 March 2025 and were signed on its behalf by
Sherif Mohamed Aboelnaga Elmasry
Director
Company Registration No. 11592190
E.P.G Pharma Ltd
Notes to the Accounts
for the year ended 30 September 2024
E.P.G Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 11592190. The registered office is MEDICITY NOTTINGHAM D6 BUILDING, THANE ROAD, NOTTINGHAM, NG90 6BH, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20% Straight line basis
Computer equipment
20% Straight line basis
4
Tangible fixed assets
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 October 2023
5,911
1,014
6,925
At 30 September 2024
5,911
1,014
6,925
At 1 October 2023
4,964
252
5,216
Charge for the year
947
203
1,150
At 30 September 2024
5,911
455
6,366
At 30 September 2024
-
559
559
At 30 September 2023
947
762
1,709
Amounts falling due within one year
E.P.G Pharma Ltd
Notes to the Accounts
for the year ended 30 September 2024
6
Creditors: amounts falling due within one year
2024
2023
Bank loans and overdrafts
4,326
8,874
Taxes and social security
-
1,216
Loans from directors
152,067
101,546
7
Creditors: amounts falling due after more than one year
2024
2023
8
Average number of employees
During the year the average number of employees was 1 (2023: 1).